Χώρα: Αρμενία
Γλώσσα: Αγγλικά
Πηγή: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate)
SmithKline Beecham Limited
J01CR02
amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate)
250mg+ 125mg
tablets film-coated
(20/2x10/) in blister
Prescription
Registered
2018-05-30
QUALITATIVE AND QUANTITATIVE COMPOSITION _AUGMENTIN_ 375 mg tablets: Each tablet contains 250 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid_ _(as potassium clavulanate). _AUGMENTIN_ 625 mg tablets: Each tablet contains 500 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid (as potassium clavulanate). _AUGMENTIN_ suspension 156 mg/5 mL: When reconstituted each 5 mL contains 125 mg amoxicillin (as amoxicillin trihydrate) and 31.25 mg clavulanic acid_ _(as potassium clavulanate). _AUGMENTIN_ suspension 312 mg/5 mL: When reconstituted each 5 mL contains 250 mg amoxicillin (as amoxicillin trihydrate) and 62.5 mg clavulanic acid (as potassium clavulanate). PHARMACEUTICAL FORM _AUGMENTIN_ 375 mg tablets: A white to off-white oval-shaped film-coated tablet, debossed with ‘Augmentin’ on one side. _AUGMENTIN_ 625 mg tablets: A white to off-white oval-shaped film-coated tablet, debossed with ‘AC’ and a score line on one side and plain on the other side. _AUGMENTIN_ suspension 156 mg/5 mL: An off-white dry powder for reconstitution in water to form a fruit flavoured suspension. _AUGMENTIN_ suspension 312 mg/5 mL: An off-white dry powder for reconstitution in water to form a fruit flavoured suspension. CLINICAL PARTICULARS Indications _AUGMENTIN_ is an antibiotic agent with a notably broad spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital. The beta-lactamase inhibitory action of clavulanate extends the spectrum of amoxicillin to embrace a wider range of organisms, including many resistant to other beta-lactam antibiotics. _AUGMENTIN_ should be used in accordance with local official antibiotic-prescribing guidelines and local susceptibility data. _AUGMENTIN_ oral presentations for three times daily dosing, are indicated for short-term treatment of bacterial infections at the following sites: _Upper respiratory tract infections (including ENT) _e.g. tonsillitis, sinusitis, otitis media. _Lower respiratory tract infections _ Διαβάστε το πλήρες έγγραφο
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT AUGMENTIN TID TABLETS AND SUSPENSION, AMOXICILLIN TRIHYDRATE - POTASSIUM CLAVULANATE 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _AUGMENTIN_ 375 mg tablets: Each tablet contains 250 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid_ _(as potassium clavulanate). _AUGMENTIN_ 625 mg tablets: Each tablet contains 500 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid (as potassium clavulanate). _AUGMENTIN_ suspension 156 mg/5 mL: When reconstituted each 5 mL contains 125 mg amoxicillin (as amoxicillin trihydrate) and 31.25 mg clavulanic acid_ _(as potassium clavulanate). _AUGMENTIN_ suspension 312 mg/5 mL: When reconstituted each 5 mL contains 250 mg amoxicillin (as amoxicillin trihydrate) and 62.5 mg clavulanic acid (as potassium clavulanate). 3. PHARMACEUTICAL FORM _AUGMENTIN_ 375 mg tablets: A white to off-white oval-shaped film-coated tablet, debossed with ‘Augmentin’ on one side. AUGMENTIN 625 mg tablets: A white to off-white oval-shaped film-coated tablet, debossed with ‘AC’ and a score line on one side and plain on the other side. _AUGMENTIN_ suspension 156 mg/5 mL: An off-white dry powder for reconstitution in water to from a fruit flavoured suspension. _AUGMENTIN_ suspension 312 mg/5 mL: An off-white dry powder for reconstitution in water to form a fruit flavoured suspension. 4. CLINICAL PARTICULARS 4.1 INDICATIONS _AUGMENTIN_ is an antibiotic agent with a notably broad spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital. The beta-lactamase inhibitory action of clavulanate extends the spectrum of amoxicillin to embrace a wider range of organisms, including many resistant to other beta-lactam antibiotics. _AUGMENTIN_ should be used in accordance with local official antibiotic-prescribing guidelines and local susceptibility data. _AUGMENTIN_ oral presentations for three times daily dosing, are indicated for short-term treatment of bacterial in Διαβάστε το πλήρες έγγραφο